June 17th, 2019
Harvard chemists’ breakthrough in synthesis advances a potent anti-cancer agent
‘Unprecedented achievement’ provides sufficient quantities of a fully synthetic halichondrin molecule for clinical trials now underway
News All News
Press Contact: Kirsten Mabry | (617) 495-4157
Tag: Licensing
June 17th, 2019
‘Unprecedented achievement’ provides sufficient quantities of a fully synthetic halichondrin molecule for clinical trials now underway
March 20th, 2018
Licensing and collaboration agreement aims to bring biomaterial-based cancer immunotherapies into clinical development
August 8th, 2017
New company will commercialize Root, an interactive robot that introduces coding to children and provides a path for continuous engagement to career-based coding languages
November 16th, 2016
Startup Magenta Therapeutics licenses technologies from Harvard, MGH, and Boston Children’s that could transform treatment
September 28th, 2016
New startup will leverage a method for simultaneously sequencing and mapping thousands of RNAs within cells and tissues to advance development of diagnostics and discover new drug targets